Enzyme Education Probiotics Full Systemic Enzymes Hybrid Systemic Enzymes Digestive Enzymes Enzymes
Knowledge Base:  
Serrapeptase: Treatment of Breast Engorgement
Last Updated: 02/18/2011

The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial.

Kee WH, Tan SL, Lee V, Salmon YM.

Singapore Med J 1989 Feb;30(1):48-54

We evaluated an anti-inflammatory enzyme drug Danzen (Serrapeptase: Takeda Chemical Industries, Ltd.) on 70 patients complaining of breast engorgement. These patients were randomly divided into 2 groups, a treatment group and a placebo group. A single observer, unaware of the group the patients were in, assessed the severity of each of the symptoms and signs of breast engorgement before treatment was commenced, and daily for 3 days, during which therapy was administered. Danzen (Serrapeptase) was noted to be superior to placebo for improvement of breast pain, breast swelling and induration and while 85.7% of the patients receiving Danzen (Serrapeptase) had "Moderate to Marked" improvement, only 60.0% of the patients receiving placebo had a similar degree of improvement. "Marked" improvement was found in 22.9% of the treatment group and 2.9% of the placebo group. These differences were statistically significant (P less than 0.05). No adverse reactions were reported with the use of Danzen (Serrapeptase). Danzen (Serrapeptase) is a safe and effective method for the treatment of breast engorgement.

Was this article helpful?


Related Articles
 > A preliminary trial of serrapeptase in patients with carpal tunnel syndrome.
 > A New Treatment for Prosthetic Infections?
 > Serrapeptase: Acute or Chronic Inflammation of Otorhinolaryngology Pathology
 > Serrapeptase: Post-antrotomy Buccal Swelling
Newsletter Sign Up
Sign up for special offers and promotions.
Customer Service
Get the Latest News
Read up on our blog and recent postings.
Copyright © Express Naturals. 2021. All Rights Reserved. Design by Built-

Built with Volusion